{Reference Type}: Journal Article
{Title}: Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
{Author}: Zandieh S;Bernt R;Mirzaei S;Haller J;Hergan K;
{Journal}: J Nucl Cardiol
{Volume}: 25
{Issue}: 4
{Year}: 08 2018
{Factor}: 3.872
{DOI}: 10.1007/s12350-016-0653-6
{Abstract}: Sarcoidosis is a systemic disorder of unknown etiology. It is distinguished by the presence of noncaseating epithelioid granulomas. This study demonstrates the use of image fusion between (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) and magnetic resonance imaging (MRI) to diagnose patients with cardiac sarcoidosis (CS).<BR>Seven patients diagnosed with sarcoidosis were retrospectively included. All patients underwent 18F-FDG PET/CT and cardiac MRI.<BR>On the MRI scan, late gadolinium enhancement (LGE) was observed in five patients. T2-weighted images revealed areas with an increased signal consistent with myocardial edema in two patients and with hypointensity suggesting fibrosis in one patient. Increased 18F-FDG uptake was seen in the myocardial wall in three patients, indicating active inflammation.<BR>18F-FDG PET and MRI image fusion allows clinicians to obtain complete morphofunctional cartography in patients with sarcoidosis. Our data show that 18F-FDG PET/MRI image fusion imaging can be useful in the diagnosis of CS.